Dr. Vijay Anand Reddy Palkonda

Dr. Vijay Anand Reddy Palkonda is one of the most esteemed Oncologist in Hyderabad.He holds an experience of 32 years in medical field. He has been been honored with “International Cancer Research Technology Transfer Award” Awarded By Uicc, Geneva, Switzerland - 1992 award, "Nargis Dutt Memorial Foundation Award” Awarded By Nargis Dutt Memorial Foundation, Flushing, New York, Usa - 1995 award, "Best Scientific Paper Award" At Xviii National Conference Of Assoc. Oncologists Of India” At Aurangabad - 1996 award, "Young Scientist Award" Awarded By Indo-american Cancer Congress, New York, Usa - 1996 award, "International Cancer Research Technology Transfer Award” Awarded By ULCC, Geneva, Switzerland - 1998 award, "Young Investigators Award" Awarded At New Delhi By Eli Lilly & Company, Usa - 2001 award, "Best Poster” Award Awarded By American Academy Of Ophthalmology At Atlanta, Ga, Usa - 2008 award, "Best Scientific Poster Award 2009” For Histopathology Of Retinoblastoma After Primary Chemotherapy. Awarded By Aroicon – 2009, Hyderabad, India. - 2009 award, "Best Scientific Paper Award 2009” For Ruthenium 106 Plaque Brachytherapy: Indications And Outcome In Ocular Tumors. Awarded By Aroicon – 2009, Hyderabad and India - 2009 award. He has completed his MBBS from Osmania University in 1983, MD - Radiotherapy from Osmania Medical College, Hyderabad in 1992, DNB - Radiotherapy from National Board of Examination and India in 1993. He carries his medicinal practice at Apollo Hospitals in Jubilee Hills(Hyderabad) and Apollo Health City in Jubilee Hills(Hyderabad). He is a respected member of American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), American Society for Therapeutic Oncology (ASTRO), Association of Radiation Oncologists of India (AROI), Indian Society of Oncology (ISO), Indian Medical Association (IMA), Indian Cooperative Oncology Network, Indian Brachytherapy Society, Foundation for Head and Neck Oncology (FHNO), Society of Neuro Oncology and USA.